Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women
Clinical trial NCT00369343 · COMPLETED
Trial details
- NCT number
- NCT00369343
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2007-11-01
- Enrollment
- 381
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.